Search Results - "KIRK, Judy"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial? by McBride, Kate A., Ballinger, Mandy L., Schlub, Timothy E., Young, Mary-Anne, Tattersall, Martin H. N., Kirk, Judy, Eeles, Ros, Killick, Emma, Walker, Leslie G., Shanley, Sue, Thomas, David M., Mitchell, Gillian

    Published in Familial cancer (01-07-2017)
    “…Germline TP53 mutation carriers are at high risk of developing a range of cancers. Effective cancer risk management is an important issue for these…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Are videoconferenced consultations as effective as face-to-face consultations for hereditary breast and ovarian cancer genetic counseling? by Zilliacus, Elvira M, Meiser, Bettina, Lobb, Elizabeth A, Kelly, Patrick J, Barlow-Stewart, Kristine, Kirk, Judy A, Spigelman, Alan D, Warwick, Linda J, Tucker, Katherine M

    Published in Genetics in medicine (01-11-2011)
    “…Purpose: Videoconferencing is increasingly used to deliver family cancer services for hereditary breast and ovarian cancer to outreach areas. This study…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    GP attitudes to and expectations for providing personal genomic risk information to the public: a qualitative study by Smit, Amelia K, Newson, Ainsley J, Keogh, Louise, Best, Megan, Dunlop, Kate, Vuong, Kylie, Kirk, Judy, Butow, Phyllis, Trevena, Lyndal, Cust, Anne E

    Published in BJGP open (01-04-2019)
    “…As part of a pilot randomised controlled trial examining the impact of personal melanoma genomic risk information on behavioural and psychosocial outcomes, GPs…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20